Makovski V et al. |
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis. |
2012 |
Int. J. Cancer |
pmid:21500191
|
Yaari-Stark S et al. |
Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc. |
2010 |
Int. J. Cancer |
pmid:19998334
|
Biran A et al. |
Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy. |
2011 |
Int. J. Cancer |
pmid:20473860
|
Egozi Y et al. |
Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist. |
1999 |
Int. J. Cancer |
pmid:10074926
|
Smalley KS and Eisen TG |
Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells. |
2003 |
Int. J. Cancer |
pmid:12673674
|
Yue W et al. |
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells. |
2005 |
Int. J. Cancer |
pmid:15957161
|
Blum R et al. |
E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition. |
2006 |
Int. J. Cancer |
pmid:16496386
|
Beiner ME et al. |
Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells. |
2006 Jan-Feb |
Int. J. Gynecol. Cancer |
pmid:16515591
|
Davey KG and Sommerville RI |
Molting in a parasitic nematode, Phocanema decipiens. VII. The mode of action of the ecdysial hormone. |
1974 |
Int. J. Parasitol. |
pmid:4853251
|
Tofts J and Meerovitch E |
The effect of farnesyl methyl ether, a mimic of insect juvenile hormone, on Hymenolepis Diminuta in vitro. |
1974 |
Int. J. Parasitol. |
pmid:4822487
|
Davey KG |
Molting in a parasitic nematode, Phocanema decipiens. VI. The mode of action of insect juvenile hormone and farnesyl methyl ether. |
1971 |
Int. J. Parasitol. |
pmid:5161204
|
Laheru D et al. |
Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer. |
2012 |
Invest New Drugs |
pmid:22547163
|
Eglin D et al. |
Farnesol-modified biodegradable polyurethanes for cartilage tissue engineering. |
2010 |
J Biomed Mater Res A |
pmid:19191318
|
Kraitzer A et al. |
Mechanisms of antiproliferative drug release from bioresorbable porous structures. |
2013 |
J Biomed Mater Res A |
pmid:23065767
|
Unnanuntana A et al. |
The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. An in vitro study. |
2009 |
J Bone Joint Surg Am |
pmid:19884443
|
Kubesová A et al. |
Separation of attogram terpenes by the capillary zone electrophoresis with fluorometric detection. |
2010 |
J Chromatogr A |
pmid:20933239
|
Cagliero C et al. |
Analysis of essential oils and fragrances with a new generation of highly inert gas chromatographic columns coated with ionic liquids. |
2017 |
J Chromatogr A |
pmid:28343686
|
Lee H et al. |
Characterization of (E,E)-farnesol and its fatty acid esters from anal scent glands of nutria (Myocastor coypus) by gas chromatography-mass spectrometry and gas chromatography-infrared spectrometry. |
2007 |
J Chromatogr A |
pmid:17709112
|
Kang L et al. |
SMGA gels for the skin permeation of haloperidol. |
2005 |
J Control Release |
pmid:15975680
|
Novák VJ |
Morphogenetic analysis of the effects of juvenile hormone analogues and other morphogenetically active substances on embryos of Schistocerca gregaria (Forskål). |
1969 |
J Embryol Exp Morphol |
pmid:5765790
|
Woodard B et al. |
3D-QSAR of fungal quorum-sensing inhibiting analogs of farnesol. |
2007 Mar-Apr |
J Environ Sci Health B |
pmid:17454380
|
Jahangir T and Sultana S |
Benzo(a)pyrene-induced genotoxicity: attenuation by farnesol in a mouse model. |
2008 |
J Enzyme Inhib Med Chem |
pmid:18618320
|
Rüegg T et al. |
3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium. |
2006 |
J Ethnopharmacol |
pmid:16266794
|
Huang J et al. |
Electrohydrodynamic deposition of nanotitanium doped hydroxyapatite coating for medical and dental applications. |
2011 |
J Mater Sci Mater Med |
pmid:21243517
|
Jamalian A et al. |
Chemical composition and antifungal activity of Matricaria recutita flower essential oil against medically important dermatophytes and soil-borne pathogens. |
2012 |
J Mycol Med |
pmid:23518164
|
Gregus P et al. |
Ultra high performance liquid chromatography tandem mass spectrometry analysis of quorum-sensing molecules of Candida albicans. |
2010 |
J Pharm Biomed Anal |
pmid:20580513
|
Teshima K and Kondo T |
Analytical method for determination of allylic isoprenols in rat tissues by liquid chromatography/tandem mass spectrometry following chemical derivatization with 3-nitrophtalic anhydride. |
2008 |
J Pharm Biomed Anal |
pmid:18313250
|
Wang Z et al. |
Farnesol for aerosol inhalation: nebulization and activity against human lung cancer cells. |
2003 Jan-Apr |
J Pharm Pharm Sci |
pmid:12753732
|
Kraitzer A et al. |
Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro. |
2011 |
J Pharm Sci |
pmid:20623695
|
Abu-Mustafa EA et al. |
Natural coumarins. XII. Umbelliprenin, a constituent of ammi majus L. fruits. |
1971 |
J Pharm Sci |
pmid:5125784
|
Wartenberg D et al. |
Proteome analysis of the farnesol-induced stress response in Aspergillus nidulans--The role of a putative dehydrin. |
2012 |
J Proteomics |
pmid:22634043
|
Riely GJ et al. |
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations. |
2011 |
J Thorac Oncol |
pmid:21847063
|
Okazaki S et al. |
[A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats]. |
1992 |
J Toxicol Sci |
pmid:1293320
|
Nagashima Y et al. |
[A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks]. |
1992 |
J Toxicol Sci |
pmid:1293321
|
Nagashima Y et al. |
[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks]. |
1992 |
J Toxicol Sci |
pmid:1293322
|
Taniguchi H et al. |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF prior to and in the early stages of pregnancy in rats]. |
1992 |
J Toxicol Sci |
pmid:1293323
|
Taniguchi H et al. |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF during the period of fetal organogenesis in rats]. |
1992 |
J Toxicol Sci |
pmid:1293324
|
Aso S et al. |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--teratogenicity study in rabbits by subcutaneous administration]. |
1992 |
J Toxicol Sci |
pmid:1293325
|
Taniguchi H et al. |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study of subcutaneous administration of PNF during the perinatal and lactation periods in rats]. |
1992 |
J Toxicol Sci |
pmid:1293326
|
Otsuka M et al. |
[Mutagenicity studies of prednisolone farnesylate (PNF)]. |
1992 |
J Toxicol Sci |
pmid:1293327
|
Uchiyama H et al. |
[Effects of prednisolone farnesylate (PNF) gel on skin and ocular mucosa]. |
1992 |
J Toxicol Sci |
pmid:1293328
|
Okazaki S et al. |
[A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks]. |
1992 |
J Toxicol Sci |
pmid:1293330
|
Okazaki S et al. |
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]. |
1992 |
J Toxicol Sci |
pmid:1293331
|
Radetich B and Corey EJ |
A general stereocontrolled, convergent synthesis of oligoprenols that parallels the biosynthetic pathway. |
2002 |
J. Am. Chem. Soc. |
pmid:11890779
|
Clarke HC et al. |
Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis. |
2003 |
J. Am. Soc. Nephrol. |
pmid:12660318
|
Williams JM and Savage CO |
Characterization of the regulation and functional consequences of p21ras activation in neutrophils by antineutrophil cytoplasm antibodies. |
2005 |
J. Am. Soc. Nephrol. |
pmid:15548565
|
Nozawa Y et al. |
Stachybotrin C and parvisporin, novel neuritogenic compounds. II. Structure determination. |
1997 |
J. Antibiot. |
pmid:9315075
|
Cerca N et al. |
Farnesol induces cell detachment from established S. epidermidis biofilms. |
2013 |
J. Antibiot. |
pmid:23549353
|
Kaneko M et al. |
Effect of farnesol on mevalonate pathway of Staphylococcus aureus. |
2011 |
J. Antibiot. |
pmid:21772307
|
Koo H et al. |
Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol. |
2003 |
J. Antimicrob. Chemother. |
pmid:14563892
|